Across TCGA pan-cancer cohorts, GOLGA8K RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated GOLGA8K data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GOLGA8K RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOLGA8K expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.
UCEC, LUSC, and COAD are the cancer types where GOLGA8K RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.